SEC ownership of Gossamer Bio, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001728117.

Comparable stake leader

683 Capital Management, LLC

Disclosed value leader

683 Capital Management, LLC

Comparable rows

50/50

Latest evidence

20 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
683 Capital Management, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
20 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001728117
Issuer location
San Diego, CA

Ownership snapshot

Top shareholders of Gossamer Bio, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
683 Capital Management, LLC
Disclosed value leader
683 Capital Management, LLC
Comparable rows
50/50
Latest evidence
20 Aug 2026
13D/G 13F Lead comparable stake: 10% 13D/G row: 683 Capital Management, LLC Showing 1-8 of 50 holder rows.

Quick read

683 Capital Management, LLC leads the comparable SEC ownership view at 10%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 683 Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
683 Capital Management, LLC 10%
Context Capital Management, LLC 9.9%
DeepCurrents Investment Group LLC 7.7%
D. E. SHAW & CO, L.P. 6%
Opaleye Management Inc. 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
683 Capital Management, LLC
13D/G 13F
Company
10%
$16,955,314
49,868,571 shares
+$13,782,671 04 Jun 2026
Context Capital Management, LLC
13D/G 13F
Company
9.9%
$16,604,168
48,835,788 shares
$0 04 Jun 2026
DeepCurrents Investment Group LLC
13D/G 13F
Company
7.7%
$12,806,125
37,665,073 shares
$0 04 Jun 2026
D. E. SHAW & CO, L.P.
13D/G
D. E. Shaw & Co., L.L.C.
6%
$5,243,075
29,128,194 shares
-$986,647 20 Aug 2026
Opaleye Management Inc.
13D/G
5.1%
$4,105,546
24,942,565 shares
$0 22 Jul 2026
Octagon Capital Advisors LP
13D/G 13F
Company
3.8%
$3,590,422
8,976,054 shares
-$2,466,148 31 Mar 2026
Invus Global Management, LLC
13D/G
Invus Public Equities, L.P.
2.8%
$5,507,814
6,258,880 shares
$0 31 Dec 2024
Growth Equity Opportunities 18 VGE, LLC
13D/G
1.7%
$10,366,092
4,065,134 shares
$0 23 Feb 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Sep 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-16 of 16 reporting-owner rows connected to Gossamer Bio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
16
Largest Forms 3/4/5 holder
Faheem Hasnain
Net 12M change
$0
Latest report
24 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Faheem Hasnain President & CEO, Director $22,610,034 Mixed 24 Aug 2026
Waage Christian EVP, Tech Ops and Admin $3,193,472 Mixed 24 Aug 2026
Bryan Giraudo Coo/Cfo $3,148,483 Mixed 24 Aug 2026
Richard Aranda Chief Medical Officer $1,685,634 Mixed 19 Mar 2026
Robert Paul Smith Jr. Chief Commercial Officer $1,034,950 Mixed 24 Aug 2026
Caryn Peterson Chief Development Officer $938,785 Mixed 24 Aug 2026
Sandra Milligan Director $111,456 Filing P/S 04 Jun 2026
Laura Carter Chief Scientific Officer $60,088 Mixed 20 Mar 2023
Russell J. Cox Director Mixed 04 Jun 2026
Skye Drynan Director Mixed 04 Jun 2026
Renee D. Gala Director Mixed 08 Jun 2023
Daniel Thomas O Director Mixed 04 Jun 2026
John D. Quisel Director Mixed 04 Jun 2026
Kristina Burow Director Mixed 08 Jun 2023
Steven D. Nathan Director Mixed 04 Jun 2026
Joshua H. Bilenker Director Mixed 09 Jun 2022

Recent insider transactions for Gossamer Bio, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Waage Christian GOSS Stock Option (Right to Buy) Award 2,900,026 2,900,026 24 Aug 2026 Direct
Caryn Peterson GOSS Stock Option (Right to Buy) Award 5,800,051 5,800,051 24 Aug 2026 Direct
Robert Paul Smith Jr. GOSS Stock Option (Right to Buy) Award 5,800,051 5,800,051 24 Aug 2026 Direct
Bryan Giraudo GOSS Stock Option (Right to Buy) Award 5,800,051 5,800,051 24 Aug 2026 Direct
Bryan Giraudo GOSS Pre-Funded Warrant (Right to Buy) Award 25 25 24 Aug 2026 By Family Trust
Faheem Hasnain GOSS Stock Option (Right to Buy) Award 5,800,051 5,800,051 24 Aug 2026 Direct
Faheem Hasnain GOSS Pre-Funded Warrant (Right to Buy) Award 166 166 24 Aug 2026 By Family Trust
John D. Quisel GOSS Stock Option (Right to Buy) Award 115,000 115,000 04 Jun 2026 Direct
Skye Drynan GOSS Stock Option (Right to Buy) Award 115,000 115,000 04 Jun 2026 Direct
Daniel Thomas O GOSS Stock Option (Right to Buy) Award 115,000 115,000 04 Jun 2026 Direct
Russell J. Cox GOSS Stock Option (Right to Buy) Award 115,000 115,000 04 Jun 2026 Direct
Sandra Milligan GOSS Stock Option (Right to Buy) Award 115,000 115,000 04 Jun 2026 Direct
Steven D. Nathan GOSS Stock Option (Right to Buy) Award 115,000 115,000 04 Jun 2026 Direct
Richard Aranda GOSS Stock Option (Right to Buy) Award 2,348,118 572,000 19 Mar 2026 Direct
Richard Aranda GOSS Stock Option (Right to Buy) Disposed to Issuer -100% -2,348,118 0 19 Mar 2026 Direct
Caryn Peterson GOSS Stock Option (Right to Buy) Award 1,992,203 506,250 19 Mar 2026 Direct
Caryn Peterson GOSS Stock Option (Right to Buy) Disposed to Issuer -100% -1,992,203 0 19 Mar 2026 Direct
Robert Paul Smith Jr. GOSS Stock Option (Right to Buy) Award 1,134,500 572,000 19 Mar 2026 Direct
Robert Paul Smith Jr. GOSS Stock Option (Right to Buy) Disposed to Issuer -100% -1,134,500 0 19 Mar 2026 Direct
Faheem Hasnain GOSS Stock Option (Right to Buy) Award 7,124,500 1,680,000 19 Mar 2026 Direct
Faheem Hasnain GOSS Stock Option (Right to Buy) Disposed to Issuer -100% -7,124,500 0 19 Mar 2026 Direct
Bryan Giraudo GOSS Stock Option (Right to Buy) Award 2,960,751 693,750 19 Mar 2026 Direct
Bryan Giraudo GOSS Stock Option (Right to Buy) Disposed to Issuer -100% -2,960,751 0 19 Mar 2026 Direct
Waage Christian GOSS Stock Option (Right to Buy) Award 2,065,584 506,250 19 Mar 2026 Direct
Waage Christian GOSS Stock Option (Right to Buy) Disposed to Issuer -100% -2,065,584 0 19 Mar 2026 Direct
Faheem Hasnain GOSS Common Stock Award 50.2% 280,000 837,793 02 Jan 2026 Direct
Faheem Hasnain GOSS Stock Option (Right to Buy) Award 1,680,000 1,680,000 02 Jan 2026 Direct
Bryan Giraudo GOSS Common Stock Award 42.2% 115,750 389,737 02 Jan 2026 Direct
Bryan Giraudo GOSS Stock Option (Right to Buy) Award 693,750 693,750 02 Jan 2026 Direct
Robert Paul Smith Jr. GOSS Common Stock Award 56.1% 93,750 260,898 02 Jan 2026 Direct
Robert Paul Smith Jr. GOSS Stock Option (Right to Buy) Award 562,500 562,500 02 Jan 2026 Direct
Richard Aranda GOSS Common Stock Award 25.4% 93,750 463,106 02 Jan 2026 Direct
Richard Aranda GOSS Stock Option (Right to Buy) Award 562,500 562,500 02 Jan 2026 Direct
Caryn Peterson GOSS Common Stock Award 48.3% 84,500 259,333 02 Jan 2026 Direct
Caryn Peterson GOSS Stock Option (Right to Buy) Award 506,250 506,250 02 Jan 2026 Direct
Waage Christian GOSS Common Stock Award 11.6% 84,500 814,061 02 Jan 2026 Direct
Waage Christian GOSS Stock Option (Right to Buy) Award 506,250 506,250 02 Jan 2026 Direct
Robert Paul Smith Jr. GOSS Common Stock Award 162,500 162,500 01 Oct 2025 Direct
Waage Christian GOSS Common Stock Award 21.3% 125,000 710,934 01 Oct 2025 Direct
Bryan Giraudo GOSS Common Stock Award 195.4% 181,250 273,987 01 Oct 2025 Direct
Richard Aranda GOSS Common Stock Award 78.6% 162,500 369,356 01 Oct 2025 Direct
Faheem Hasnain GOSS Common Stock Award 363.7% 437,500 557,793 01 Oct 2025 Direct
Caryn Peterson GOSS Common Stock Award 250.8% 125,000 174,833 01 Oct 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .